Skip to main content
. 2018 May 30;99(5):1082–1090. doi: 10.1093/biolre/ioy127

Figure 1.

Figure 1.

Anticoagulant properties of dalteparin and gsHep. (A) Glycol-split heparin had negligible anti-Factor Xa activity compared to dalteparin at all concentrations tested. (B) Glycol-split heparin had significantly reduced ability to prolong aPTT clotting time compared to dalteparin at concentrations beyond 5 μg/mL. ***P < 0.0001 compared to dalteparin at equivalent concentration. aPTT, activated partial thromboplastin time. n = 3 independent experiments.